AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma
Clinical trial NCT05985694 · COMPLETED
Trial details
- NCT number
- NCT05985694
- Sponsor
- Advagene Biopharma Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2025-01-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.